Nottingham Trent University, Clifton campus
Nottingham, NG11 8NS, United Kingdom
Location status: Recruiting
NCT Number: NCT07196514
Curcumin (a bioactive compound found in turmeric) has demonstrated anti-inflammatory and antioxidant properties, and there is evidence to suggest that it may produce improvements in quality of life and markers of health in humans with various conditions. To date, the research has often focussed on the effects of curcumin in human participants with a particular condition. However, turmeric contains hundreds of other bioactive compounds (including other curcuminoids and essential oils) and may be able to benefit a wide range of older adults. Therefore, the aim of this study is to investigate the effects of twice daily consumption of a turmeric beverage for 8-weeks on the physiology and wellbeing of older adults (versus placebo).
Interested in participating?
Request Info40 year–95 year
All sexes
Interventional
Not applicable
Nottingham, NG11 8NS, United Kingdom
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This group will take one 60 mL commercially-available shot (containing 30% turmeric) twice per day for 8 weeks.
This group will take one placebo shot (containing a small amount of turmeric for taste-matching purposes) twice per day for 8 weeks.
Time frame: Two timepoints: 1) baseline 2) after 8 week intervention
Measured using ELISA. We will analyse raw and percentage change values.
Time frame: Two timepoints: 1) baseline 2) after 8 week intervention
Measured using pentra C400 clinical chemistry analyser, We will analyse raw and percentage change values.
Time frame: Two timepoints: 1) baseline 2) after 8 week intervention
This questionnaire measures participants' severity of physical and mental fatigue. This will be scored "Likert style" from 0-33. Higher scores indicate greater levels of fatigue.
Time frame: Two timepoints: 1) baseline 2) after 8 week intervention
Measured using pentra C400 clinical chemistry analyser, We will analyse raw and percentage change values.
Time frame: Two timepoints: 1) baseline 2) after 8 week intervention
Participants choose from a range of questions designed to measure the severity of a range of symptoms common to both depression and anxiety. Scoring is based on a likert scale where higher scores relate to increased severity of depression, anxiety and stress.
Time frame: Two timepoints: 1) baseline 2) after 8 week intervention
This questionnaire is used to evaluate a person experiencing significant pain. It can be used to monitor pain over time. Someone experiencing no pain would score 0 while the maximum score for pain would be 78.
Time frame: Two timepoints: 1) baseline 2) after 8 week intervention
This survey consists of generic questions covering eight health domains: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions. To score the survey, firstly, responses to items relate to scores between 0-100. Secondly, using a table, items in the same scale are averaged together to create the eight domains.
Time frame: Two timepoints: 1) baseline 2) after 8 week intervention
Measured using pentra C400 clinical chemistry analyser, We will analyse raw and percentage change values.
Time frame: Two timepoints: 1) baseline 2) after 8 week intervention
Measured using pentra C400 clinical chemistry analyser, We will analyse raw and percentage change values.
Time frame: Two timepoints: 1) baseline 2) after 8 week intervention
Measured using pentra C400 clinical chemistry analyser, We will analyse raw and percentage change values.
Time frame: Two timepoints: 1) baseline 2) after 8 week intervention
Measured using pentra C400 clinical chemistry analyser, We will analyse raw and percentage change values.
Time frame: Two timepoints: 1) baseline 2) after 8 week intervention
Measured using pentra C400 clinical chemistry analyser, We will analyse raw and percentage change values.
Time frame: Two timepoints: 1) baseline 2) after 8 week intervention
Measured using pentra C400 clinical chemistry analyser, We will analyse raw and percentage change values.
Time frame: Two timepoints: 1) baseline 2) after 8 week intervention
Measured using pentra C400 clinical chemistry analyser, We will analyse raw and percentage change values.
Time frame: Two timepoints: 1) baseline 2) after 8 week intervention
Measured using pentra C400 clinical chemistry analyser, We will analyse raw and percentage change values.
Time frame: Two timepoints: 1) baseline 2) after 8 week intervention
Measured using pentra C400 clinical chemistry analyser, We will analyse raw and percentage change values.
Time frame: Two timepoints: 1) baseline 2) after 8 week intervention
Measured using pentra C400 clinical chemistry analyser, We will analyse raw and percentage change values
Time frame: Two timepoints: 1) baseline 2) after 8 week intervention
Measured using pentra C400 clinical chemistry analyser, We will analyse raw and percentage change values
Time frame: Two timepoints: 1) baseline 2) after 8 week intervention
Systolic and diastolic blood pressure will be determined using an automatic upper arm blood pressure monitor. We will analyse raw and percentage change values.
Time frame: Two timepoints: 1) baseline 2) after 8 week intervention
Determined by weighing participants.
Time frame: Two timepoints: 1) baseline 2) after 8 week intervention
The PSQI is a tool used for assessing quality and disturbances over a one-month period. The sum of scores for the following 7 components, subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication and daytime function, are used to calculate a global PSQI score with scores greater than 5 indicating poor sleep quality.
Time frame: Two timepoints: 1) baseline 2) after 8 week intervention
This particular N-back tast comprises of only the 2-Back memory load. The total stimulus set is 15. Participants respond using the space bar when they see a stimulus that is presented two steps previously. There are three blocks consisting of 25 trials. Each stimulus will be presented for 500 ms and get 3 seconds to respond unless the participant responds earlier in which case the next trial will begin. Errors, correct responses, misses and reaction time, will be used as indices of performance. Commission errors or 'false alarms' occur when participants respond to non-targets.
Time frame: Two timepoints: 1) baseline 2) after 8 week intervention
Participants are shown squares/blocks that light up one-by-one in a random order starting in a sequence length of two blocks. Participants then click with the mouse the blocks in exactly the same order as shown before. One extra square is added to each successfully completed sequence. If the participant fails to click the correct sequence they get one more chance with a different pattern and same sequence length. If they get it wrong again, the test ends and their score is shown (the corsi block span).
Time frame: Two timepoints: 1) baseline 2) after 8 week intervention
This test is the reverse of the forward version. Participants are shown squares/blocks that light up one-by-one in a random order starting in a sequence length of two blocks. Participants then click with the mouse the blocks in the reverse order as shown before. One extra square is added to each successfully completed sequence. If the participant fails to click the correct sequence, they get one more chance with a different pattern and same sequence length. If they get it wrong again, the test ends and their score in shown (the corsi block span).
Time frame: Two timepoints: 1) baseline 2) after 8 week intervention
The objective of this test is to complete as many sit-to-stand repetitions as possible in 30 seconds. Participants will be instructed to sit in the middle of a chair placed against the wall with a seat height of 43 cm. Participants start with their feet flat on the floor, arms crossed at the wrists and held against the chest. On the signal, participants will rise to a full stand and return back to a fully seated position (counting as one full repetition). Before the test, participants will be allowed to practice 1-2 times to familiarise themselves with the movement
Time frame: Two timepoints: 1) baseline 2) after 8 week intervention
Participants will start by holding a hand grip dynamometer with their arm at a right angle and the elbow should be by the side of the body. The grip length will be noted and kept the same post intervention laboratory visit. Once the participant has a comfortable grip on the dynamometer they will squeeze the dynamometer with maximum isometric effort and maintain it for at least 5 seconds. No other body movement is allowed. The value shown on the dynamometer in kilograms will be recorded. Participants will alternate hands attempting the test three times with each hand.
Time frame: Two timepoints: 1) baseline 2) after 8 week intervention
The objective of this test is to complete as many steps (with the knee reaching the marking) in 2-minutes as possible. To mark the line for the knee to cross, the distance between participant's anterior iliac crest and their patella will be measured and the midpoint will be found. A piece of tape will be placed on the stadiometer corresponding height of the midpoint between the patella and the iliac crest. The final score will be the number of times the right knee reached the tape height.
Time frame: Two timepoints: 1) baseline 2) after 8 week intervention
Time frame: Two timepoints: 1) baseline 2) after 8 week intervention
Time frame: Two one week periods: One week prior to intervention (baseline) and last week of intervention (week 8)
A wrist monitor will allow for classifications of physical activity intensities (sedentary behaviour, light intensity physical activity, moderate intensity physical activity, moderate-vigorous intensity physical activity and vigorous intensity physical activity) and durations of time spent in these classifications.
Time frame: Two timepoints: 1) baseline 2) after 8 week intervention
Participants that have osteoarthritis will complete this questionnaire. The highest possible score is 96, which indicates the maximum pain, stiffness and difficulty with physical function.
Time frame: Two timepoints: 1) Baseline 2) after 8 week intervention
Pain medication usage over the prior 8 weeks will be assessed using a modified version of the Quantitative Analgesic Questionnaire.
Nottingham Trent University
Other
Exploring the Effects of an 8-week Turmeric Supplementation on Aspects of Physiology and Wellbeing in Healthy Older Adults
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06214923
Craniomandibular Disorders, Jaw Diseases
Baltimore, Maryland, United States
View Trial DetailsNCT05007561
Naltrexone, Placebo
San Diego, California, United States
View Trial DetailsNCT05145764
Chemically-Induced Disorders, Dyssomnias
Baltimore, Maryland, United States
View Trial DetailsNCT06667180
Behavior, Behavioral Symptoms
León, Guanajuato, Mexico
View Trial Details